Evaluation of CXCL12 and CXCR4 to predict poor survival in lymph node-positive colorectal cancer patients

Mehmet Zengin; Nevra Dursun; Kemal Behzatoğlu; Hüsniye Esra Paşaoğlu; Suat Benek

doi:10.5114/pjp.2020.103713

eISSN: 2084-9869
ISSN: 1233-9687

Polish Journal of Pathology

Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

4/2020
vol. 71

Send email

Copy url:

abstract:

Original paper

Evaluation of CXCL12 and CXCR4 to predict poor survival in lymph node-positive colorectal cancer patients

Mehmet Zengin

¹

,

Nevra Dursun

²

,

Kemal Behzatoğlu

³

,

Hüsniye Esra Paşaoğlu

⁴

,

Suat Benek

⁵

Kırıkkale University Faculty of Medicine, Department of Pathology, Kırıkkale, Turkey
Istanbul Education and Research Hospital, Department of Pathology, Istanbul, Turkey
Acıbadem University Faculty of Medicine, Department of Pathology, Istanbul, Turkey
Bağcılar Training and Research Hospital, Department of Pathology, Istanbul, Turkey
Tekirdağ University Faculty of Medicine, Department of General Surgery, Istanbul, Turkey

Pol J Pathol 2020; 71 (4): 328-338

DOI: https://doi.org/10.5114/pjp.2020.103713

Online publish date: 2021/02/22

View full text Get citation

PlumX metrics:

It is well known that interactions in the tumour microenvironment are very important in the progression of tumours. We investigated the relationship between chemokine ligand type 12 (CXCL12), chemokine receptor type 4 (CXCR4) and survival in advanced colorectal cancers (CRC). Primary tumour samples of stage III-IV CRC patients were investigated for CXCL12 and CXCR4. Chemokine ligand type 12 and CXCR4 expressions were significantly associated with poor prognostic factors (e.g. for CXCL12: lymphatic invasion [p = 0.009], positive surgical margin [p = 0.006], advanced stage [p = 0.028], etc.). Also, these parameters were independent risk factors for low LIR (e.g. for CXCL12: Odds ratio [OR] = 2.27, p = 0.001) and low tumour stroma-ratio (TSR; e.g. for CXCL12: OR = 1.18, p = 0.003). In univariate analysis, 5-year RFS and OS were poor (e.g. for CXCL12: RFS, p < 0.001 and OS, p = 0.001). Multivariate analysis showed that these parameters were independent poor survival parameters for RFS and OS (e.g. for CXCL12: Hazard ratio [HR] = 3.54 [CI: 1.52-4.67], p = 0.001 and HR = 2.74 [1.48-4.71], p = 0.025). We showed that CXCL12 and CXCR4 expressions are poor prognostic factors in lymph node-positive CRC patients and are associated with low TSR and low LIR.

keywords:

Evaluation of CXCL12 and CXCR4 to predict poor survival in lymph node-positive colorectal cancer patients

Mehmet Zengin 1 , Nevra Dursun 2 , Kemal Behzatoğlu 3 , Hüsniye Esra Paşaoğlu 4 , Suat Benek 5

colorectal cancers, CXCL12, CXCR4, prognostic markers, stage III-IV

Mehmet Zengin

¹

,

Nevra Dursun

²

,

Kemal Behzatoğlu

³

,

Hüsniye Esra Paşaoğlu

⁴

,

Suat Benek

⁵